#retatrutide Retatrutide Subcutaneous Fat Loss Results: What Clinical Trials Reveal About Effectiveness and Safety What to Know About Retatrutide

The response from many of those employers has been swift: Blue Cross Blue Shield of Massachusetts dropped GLP-1 coverage for obesity treatment for employers with fewer than 100 employees at the start of 2026 Harvard Pilgrim Health Care and Blue Cross Blue Shield of Michigan both dropped weight-loss GLP-1 coverage in 2026 HCA Healthcare one of the countrys largest hospital systems notified employees that its GLP-1 coverage was ending after usage surged 90% in a single year, directing workers instead toward manufacturer cash-pay programs Several other employers have stopped short of elimination but have tightened requirements dramatically restricting coverage only to patients with a formal diabetes diagnosis and removing access for patients using GLP-1s for weight management alone. Why Are Employers Cutting This Coverage Now

Skip Navigation Markets Pre-Markets U.S

Both now face losing access

follow your doctors instructions

You can sign up for a prescription discount card that can save up to 80% whether you use insurance or pay out-of-pocket

UK Research Peptides, Cold-Chain Verified The UK's only research peptide supplier with UKAS verified HPLC testing, Type 1 hydrolytic glass vials, and full -20C cold chain